Complaint

Lowey Dannenberg Notifies Lincoln National Corporation (“Lincoln National” or “the Company”) (NYSE: LNC) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm

Retrieved on: 
Friday, May 3, 2024
Action Replay, Bank statement, Complaint, Lincoln National Corporation, VUL, Luna Innovations, Policy, LNC

NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Lincoln National Corporation (“Lincoln National” or “the Company”) (NYSE: LNC) for violations of the federal securities laws on behalf of investors who purchased or acquired Luna Innovations common stock between November 4, 2020 and November 2, 2022, inclusive (the “Class Period”).

Key Points: 
  • NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Lincoln National Corporation (“Lincoln National” or “the Company”) (NYSE: LNC) for violations of the federal securities laws on behalf of investors who purchased or acquired Luna Innovations common stock between November 4, 2020 and November 2, 2022, inclusive (the “Class Period”).
  • When investors learned the truth, Lincoln National’s common stock declined precipitously, injuring investors.
  • If you suffered a loss of more than $50,000 in Lincoln National’s securities, and wish to participate, or learn more, please contact our attorneys at (914) 733-7256 or via email to Andrea Farah ([email protected]) or Vincent R. Cappucci Jr. ([email protected]).
  • Any investor who wishes to serve as Lead Plaintiff must act before June 24, 2024.

EQUINIX, INC. (NASDAQ: EQIX) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Equinix, Inc.

Retrieved on: 
Friday, May 3, 2024
EQIX, News, Real estate investment trust, Complaint, Hindenburg Research, The Insider, Action Replay, District court, Audit committee, Court, Hindenburg, Advertising, Security (finance)

Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Equinix, Inc. (“Equinix” or the “Company”) (NASDAQ: EQIX) between May 3, 2019 and March 24, 2024, inclusive (the “Class Period”).

Key Points: 
  • Bernstein Liebhard LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Equinix, Inc. (“Equinix” or the “Company”) (NASDAQ: EQIX) between May 3, 2019 and March 24, 2024, inclusive (the “Class Period”).
  • If you purchased or acquired Equinix securities, and/or would like to discuss your legal rights and options please visit Equinix, Inc.
  • Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or [email protected] .
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Malibu Boats, Inc. (MBUU)

Retrieved on: 
Friday, May 3, 2024
Sale, Malibu Boats, News, Suite, Complaint, GPM, Defendant, Court, Boat, Cryptocurrency

On February 20, 2024, before the market opened, Malibu Boats announced the Company’s Chief Executive Officer (“CEO”) had “mutually agreed” to cease to serve as CEO.

Key Points: 
  • On February 20, 2024, before the market opened, Malibu Boats announced the Company’s Chief Executive Officer (“CEO”) had “mutually agreed” to cease to serve as CEO.
  • Then, on April 11, 2024, after the market closed, Malibu Boats revealed that Tommy’s Boats (“Tommy’s”) had filed a complaint against the Company.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

Class Action Filed Against bluebird bio, Inc. (BLUE) - May 28, 2024 Deadline to Join – Contact Levi & Korsinsky

Retrieved on: 
Friday, May 3, 2024
Sickle cell disease, FDA, LLP, News, CLASS, Food, Blue, NEXT, AML, History, Complaint, Patient, Court, Telephone, COST, Bluebird bio

NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in bluebird bio, Inc. ("bluebird bio" or the "Company") (NASDAQ: BLUE) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in bluebird bio, Inc. ("bluebird bio" or the "Company") (NASDAQ: BLUE) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of bluebird bio investors who were adversely affected by alleged securities fraud between April 24, 2023 and December 8, 2023.
  • Follow the link below to get more information and be contacted by a member of our team:
    BLUE investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocugen, QuidelOrtho, Sharecare, and GoodRx and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, May 3, 2024
Sale, FDA, News, Risk, Food, Sharecare, PBM, Complaint, Plasma protein binding, P.C, Defendant, COVID-19, Shareholder, Diagnosis, Infection, QuidelOrtho, Bank statement, GoodRx, Pharmacy, Pharmaceutical industry

For more information on the Ocugen class action go to: https://bespc.com/cases/OCGN

Key Points: 
  • For more information on the Ocugen class action go to: https://bespc.com/cases/OCGN
    QuidelOrtho provides tests for the detection and diagnosis of various respiratory diseases and other medical conditions.
  • The Company’s respiratory business has historically been tied to the sale of seasonal flu tests and more recently to COVID-19 detection tests.
  • In December 2022, the Company announced that it had agreed to merge with Ortho Clinical Diagnostics Holdings plc (“Ortho”).
  • For more information on the GoodRx class action go to: https://bespc.com/cases/GDRX

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Checkpoint, Sonder, Perion, and Autodesk and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, May 3, 2024
FDA, Radiation, CMO, Sonder, ChatGPT, News, Risk, Food, Annual report, Complaint, Biologics license application, P.C, Microsoft, Patient, ADSK, Acquisition, CKPT, BLA, Bank statement, CRL, Growth, Audit

The Company relies on third-party contract manufacturers to, inter alia, conduct its preclinical and clinical studies and trials, as well as to complete commercial and pre-commercial manufacturing.

Key Points: 
  • The Company relies on third-party contract manufacturers to, inter alia, conduct its preclinical and clinical studies and trials, as well as to complete commercial and pre-commercial manufacturing.
  • The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies.
  • For more information on the Sonder class action go to: https://bespc.com/cases/SOND
    Perion’s most significant search partner and largest source of revenue is Microsoft.
  • For more information on the Autodesk class action go to: https://bespc.com/cases/ADSK

OCGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ocugen, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Friday, May 3, 2024
Bank statement, Complaint, Court, Person

Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/OCGN .

Key Points: 
  • Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/OCGN .
  • When the true details entered the market, the lawsuit claims that investors suffered damages.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

BLUE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that bluebird bio, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Friday, May 3, 2024
Sickle cell disease, FDA, Cancer, DSM-IV codes, SCD, News, Food, Blue, Complaint, Class, Bluebird bio, History, Patient, Court, BLA, File, Biotechnology, Person, Pharmaceutical industry

According to the Complaint, Blue is a biotechnology company that researches, develops, and commercializes gene therapies for severe genetic diseases.

Key Points: 
  • According to the Complaint, Blue is a biotechnology company that researches, develops, and commercializes gene therapies for severe genetic diseases.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • If you suffered a loss in Blue you have until May 28, 2024, to request that the Court appoint you as lead plaintiff.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

SOND INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sonder Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Retrieved on: 
Friday, May 3, 2024
Annual report, Complaint, Court, Bank statement, Person

NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sonder Holdings Inc. (“Sonder” or “the Company”) (NASDAQ: SOND) and certain of its officers.

Key Points: 
  • NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sonder Holdings Inc. (“Sonder” or “the Company”) (NASDAQ: SOND) and certain of its officers.
  • Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/SOND .
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.

INVZ INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Innoviz Technologies Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Friday, May 3, 2024
Aptiv, News, FY, Complaint, Original equipment manufacturer, Volkswagen, Court, BMW, Perception, Person, Cryptocurrency

Innoviz designs and manufactures solid-state light detection and ranging, or “LiDAR”, sensors and develops perception software that purportedly enables the mass production of autonomous vehicles.

Key Points: 
  • Innoviz designs and manufactures solid-state light detection and ranging, or “LiDAR”, sensors and develops perception software that purportedly enables the mass production of autonomous vehicles.
  • or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 332-239-2660.
  • If you suffered a loss in Innoviz you have until May 14, 2024, to request that the Court appoint you as lead plaintiff.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.